Position in LLY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$92,848,022
-$127,463,547 QoQ
Shares Held
100,947
-50.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$82,591,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS holds $547,855,762 across 11 Drug Manufacturers - General names. LLY ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
2,068,064 | $125,428,081 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
100,947 | $92,848,022 | |
| 3 | NVO |
Novo Nordisk A S
|
2,005,285 | $73,694,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
510,056 | $61,354,636 | |
| 5 | PFE |
Pfizer Inc
|
1,912,234 | $53,695,530 | |
| 6 | JNJ |
Johnson & Johnson
|
213,825 | $52,267,383 | |
| 7 | ABBV |
AbbVie Inc.
|
233,196 | $50,717,798 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
156,715 | $21,841,369 |
All Filings in LLY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,848,022 | 100,947 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $220,311,569 | 205,002 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $186,429,894 | 244,338 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $188,687,575 | 242,053 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $271,328,779 | 328,521 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $82,591,000 | 100,000 | Put | Sole | 2025-07-18 | |
| 2024-12-31 | $106,516,700 | 137,975 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $205,540,737 | 232,003 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $143,179,509 | 158,143 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $172,330,587 | 221,516 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $92,020,917 | 157,862 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $118,446,833 | 220,518 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $164,177,235 | 350,073 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $17,557,004 | 51,124 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $74,354,053 | 203,242 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $2,263 | 7 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $110,199,943 | 340,807 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,890 | 12 | Call | Sole | 2022-08-12 | |
| 2022-06-30 | $40,894,805 | 126,129 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $79,462,806 | 277,483 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $35,968,539 | 130,217 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,774,214 | 76,928 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $21,452,775 | 93,468 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,296,673 | 22,999 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $61,884,249 | 366,526 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $33,833,375 | 228,573 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $25,526,213 | 155,477 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,230,756 | 16,081 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||